1. Home
  2. IFBD vs BGLC Comparison

IFBD vs BGLC Comparison

Compare IFBD & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Infobird Co. Ltd

IFBD

Infobird Co. Ltd

N/A

Current Price

$1.00

Market Cap

8.4M

Sector

Technology

ML Signal

N/A

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$2.67

Market Cap

10.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IFBD
BGLC
Founded
2001
2017
Country
China
Malaysia
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
10.1M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
IFBD
BGLC
Price
$1.00
$2.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
68.8K
10.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.78
EPS
N/A
N/A
Revenue
N/A
$9,510,646.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$0.23
52 Week High
$1.73
$15.19

Technical Indicators

Market Signals
Indicator
IFBD
BGLC
Relative Strength Index (RSI) 52.47 48.43
Support Level $0.97 $2.57
Resistance Level $1.09 $5.02
Average True Range (ATR) 0.05 0.14
MACD 0.00 0.09
Stochastic Oscillator 70.58 78.57

Price Performance

Historical Comparison
IFBD
BGLC

About IFBD Infobird Co. Ltd

Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: